e-learning
resources
Stockholm 2007
Monday 17.09.2007
Biology of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vascular endothelial growth factor and oxidative stress in patients with primary lung cancer
A. Katsabeki, T. Kerenidi, K. Kostikas, T. Kiropoulos, E. Dalaveris, K. Gourgoulianis (Larissa, Greece)
Source:
Annual Congress 2007 - Biology of thoracic malignancies
Session:
Biology of thoracic malignancies
Session type:
Electronic Poster Discussion
Number:
1823
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Katsabeki, T. Kerenidi, K. Kostikas, T. Kiropoulos, E. Dalaveris, K. Gourgoulianis (Larissa, Greece). Vascular endothelial growth factor and oxidative stress in patients with primary lung cancer. Eur Respir J 2007; 30: Suppl. 51, 1823
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Serum levels of vascular endothelial growth factor in lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004
Expression of vascular endothelial-cadherin and vascular endothelial growth factor in non-small cell lung cancer and their clinical significances
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Vascular endothelial growth factor in sera of patients with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005
The role of serum adhesion molecules and vascular endothelial growth factor in the treatment approach of the lung cancer patients
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Imbalance between vascular endothelial growth factor and endostatin in emphysema
Source: Eur Respir J 2003 Oct 01;22(4):609-612
Year: 2003
PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005
Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Source: Eur Respir J 2002; 20: 1449-1456
Year: 2002
A role for vascular endothelial growth factor (VEGF) in fibrosis?
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006
Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma
Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma
Year: 2004
Tissue levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase, vascular endothelial growth factor and cathepsin-D in patients with brochogenic cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 328s
Year: 2005
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept